Notice: unserialize(): Error at offset 2 of 31 bytes in /data/html/www_bioworld_com/includes/bootstrap.inc on line 559 Notice: unserialize(): Error at offset 2753 of 5598 bytes in /data/html/www_bioworld_com/includes/bootstrap.inc on line 559 Clinic Roundup | BioWorld

Login to Your Account



Clinic Roundup


Wednesday, November 21, 2012
• Atox Bio Ltd., of Ness Ziona, Israel, reported top-line results from a Phase IIa trial showing that AB103, a short peptide immune regulatory therapy, produced meaningful improvement across multiple endpoints vs. placebo in patients with necrotizing soft-tissue infections.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription